Arsenal Capital Partners, a private equity firm specialising in healthcare and industrial companies, has expanded its team with the addition of Raymond Hill as an Operating Partner.
In his new role, Hill will work within the firm’s healthcare team and will focus on pharmaceutical services investment themes and portfolio companies.
Most recently, Hill served as Chairman and CEO of biopharmaceutical data provider CorEvitas.
Prior to CorEvitas, he was President of clinical research organisation InVentiv Clinical (now Syneos Health) and President of life sciences solutions provider IMS Health (now IQVIA).
